Internal Medicine, Gastroenterology · Bettendorf, IA
NPI
1407830912
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2222 53rd Ave
Bettendorf, IA, 52722
Phone (563) 383-2686
Groups this clinician bills Medicare through
Medicare paid, 2024
$142K
1,484 services
Medicare patients, 2024
666
Average age 73
Drug cost, 2024
$305K
2,222 prescriptions
Company payments, 2023
$112
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Young B Huh was code 45380 (lower gi endoscopy - other), 256 times for 255 patients. In total Young B Huh billed 1,484 services in 36 codes, and Medicare paid $142K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45380 Lower GI Endoscopy - Other | Facility | 256 | 255 | $49.56 | $13K |
| 45385 Colonoscopy - Lesion Removal | Facility | 199 | 199 | $178.71 | $36K |
| 99204 Office E&M - New | Office | 190 | 190 | $108.62 | $21K |
| 43239 Upper GI Endoscopy | Facility | 187 | 182 | $36.19 | $6,768 |
| 99214 Office E&M - Established | Office | 116 | 113 | $86.42 | $10K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 89 | 89 | $158.70 | $14K |
| 43251 Upper GI Endoscopy | Facility | 79 | 76 | $124.25 | $9,815 |
| 99203 Office E&M - New | Office | 62 | 62 | $71.22 | $4,415 |
| 43249 Upper GI Endoscopy | Facility | 57 | 56 | $50.10 | $2,855 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 41 | 41 | $154.74 | $6,344 |
| 99213 Office E&M - Established | Office | 38 | 36 | $62.72 | $2,383 |
| 45378 Lower GI Endoscopy - Other | Facility | 33 | 33 | $103.40 | $3,412 |
| 91065 Test - Miscellaneous | Office | 32 | 21 | $42.80 | $1,370 |
| 46221 Digestive/Gastrointestinal | Facility | 23 | 23 | $92.14 | $2,119 |
| 45390 Lower GI Endoscopy - Other | Facility | 21 | 21 | $247.71 | $5,202 |
By year: 2022 $141K for 1,484 services; 2023 $144K for 1,564 services; 2024 $142K for 1,484 services.
Medicare prescription drug claims, 2024
In 2024, the drug Young B Huh prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 645 prescriptions and refills. In total Young B Huh wrote 2,222 Medicare prescriptions that cost $305K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 645 | 645 | 638 | $41K |
| Omeprazole Generic | 487 | 1,281 | 159 | $5,495 |
| Famotidine Generic | 218 | 514 | 65 | $2,348 |
| Pantoprazole Sodium Generic | 207 | 488 | 68 | $2,316 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 69 | 69 | 68 | $946 |
| Dexlansoprazole Dr Dexlansoprazole | 44 | 107 | Under 11 | $21K |
| Linzess Linaclotide | 42 | 90 | 12 | $48K |
| Sulfasalazine Generic | 36 | 101 | 11 | $1,983 |
| Lansoprazole Generic | 32 | 48 | Under 11 | $610 |
| Sucralfate Generic | 26 | 46 | Under 11 | $1,070 |
| Mesalamine Dr Mesalamine | 24 | 26 | Under 11 | $1,609 |
| Enulose Lactulose | 23 | 23 | 23 | $29.99 |
| Mesalamine Generic | 23 | 65 | Under 11 | $19K |
| Ciprofloxacin Hcl Generic | 22 | 22 | 20 | $136 |
| Cholestyramine Cholestyramine (With Sugar) | 21 | 25 | 12 | $1,733 |
Brand drugs: - claims; generic drugs: 1,835 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Young B Huh $112 ($112 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $63.72.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $63.72 |
| Nestle Healthcare Nutrition Inc. | 3 | $48.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.